REVIEW Nitrendipine is a racemic dihydropyridine calcium channel blocker for the treatment of primary hypertension.
REFERENCES
[1]
Meyer, Horst; Bossert, Friedrich; Vater, Wulf; Stoepel, Kurt Dialkyl 4-aryl-2,6-dimethyl-1,4-dihydro-3,5-pyridinedicarboxylates Ger. Offen. (1972), DE 2117571 A 19721019.
[2]
Meyer, H.; Bossert, F.; Wehinger, E.; Stoepel, K.; Vater, W. Synthesis and comparative pharmacological studies of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylates with non-identical ester functions Arzneimittel-Forschung (1981), 31(3), 407-9.
[3]
Meyer, Horst; Bossert, Friedrich; Wehinger, Egbert; Scherling, Dietrich Chemistry of nitrendipine and its metabolites Edited by Scriabine, Alexander; Vanov, Svetislav; Deck, Klaus Nitrendipine (1984), 1-9.
[4]
Goa KL, Sorkin EM. Nitrendipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs. 1987 Feb;33(2):123-55.
For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.